MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 4, 2007; DOI: 10.1124/mol.107.035980


0026-895X/07/7206-1447-1456$20.00
Mol Pharmacol 72:1447-1456, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.035980v1
72/6/1447    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, C.
Right arrow Articles by Murrell-Lagnado, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, C.
Right arrow Articles by Murrell-Lagnado, R. D.

Evidence for Functional P2X4/P2X7 Heteromeric ReceptorsFormula

Chang Guo, Marianela Masin, Omar S. Qureshi, and Ruth D. Murrell-Lagnado

Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom

The cytolytic ionotropic ATP receptor P2X7 has several important roles in immune cell regulation, such as cytokine release, apoptosis, and microbial killing. Although P2X7 receptors are frequently coexpressed with another subtype of P2X receptor, P2X4, they are believed not to form heteromeric assemblies but to function only as homomers. Both receptors play a role in neuropathic pain; therefore, understanding how they coordinate the cellular response to ATP is important for the development of effective pain therapies. Here, we provide biochemical and electrophysiological evidence for an association between P2X4 and P2X7 that increases the diversity of receptor currents mediated via these two subtypes. The heterologously expressed receptors were coimmunoprecipitated from human embryonic kidney (HEK) 293 cells, and the endogenous P2X4 and P2X7 receptors were similarly coimmunoprecipitated from bone marrow-derived macrophages. In HEK293 cells, the fraction of P2X4 receptors biotinylated at the plasma membrane increased 2-fold in the presence of P2X7 although there was no change in overall expression. Coexpression of a dominant-negative P2X4 mutant (C353W) with P2X7, inhibited P2X7 receptor mediated currents by greater than 2-fold, whereas a nonfunctional but non–dominant-negative mutant (S341W) did not. Coexpression of P2X4S341W with P2X7 produced a current that was potentiated by ivermectin and inhibited by 2',3'-O-(2,4,6-trinitrophenyl) adenosine 5-triphosphate (TNP-ATP), whereas expression of P2X7 alone produced a current that was insensitive to both of these compounds at the concentrations used. These results demonstrate a structural and functional interaction between P2X4 and P2X7, which suggests that they associate to form heteromeric receptors.


Address correspondence to: Dr. Ruth Murrell-Lagnado, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom. E-mail: rdm1003{at}cam.ac.uk


Related articles in MolPharm:

Go It Alone No More—P2X7 Joins the Society of Heteromeric ATP-Gated Receptor Channels
George R. Dubyak
MolPharm 2007 72: 1402-1405. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
J. Physiol.Home page
R. Murrell-Lagnado
More cross-talk between purinergic receptors
J. Physiol., June 15, 2009; 587(12): 2713 - 2714.
[Full Text] [PDF]


Home page
J. Physiol.Home page
G. Casas-Pruneda, J. P. Reyes, G. Pérez-Flores, P. Pérez-Cornejo, and J. Arreola
Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia
J. Physiol., June 15, 2009; 587(12): 2887 - 2901.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. R. J. Taylor, M. Gonzalez-Begne, D. K. Sojka, J. C. Richardson, S. A. Sheardown, S. M. Harrison, C. D. Pusey, F. W. K. Tam, and J. I. Elliott
Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses
J. Leukoc. Biol., June 1, 2009; 85(6): 978 - 986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Boumechache, M. Masin, J. M. Edwardson, D. C. Gorecki, and R. Murrell-Lagnado
Analysis of Assembly and Trafficking of Native P2X4 and P2X7 Receptor Complexes in Rodent Immune Cells
J. Biol. Chem., May 15, 2009; 284(20): 13446 - 13454.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Skals, N. R. Jorgensen, J. Leipziger, and H. A. Praetorius
{alpha}-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis
PNAS, March 10, 2009; 106(10): 4030 - 4035.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nakamoto, D. A. Brown, M. A. Catalan, M. Gonzalez-Begne, V. G. Romanenko, and J. E. Melvin
Purinergic P2X7 Receptors Mediate ATP-induced Saliva Secretion by the Mouse Submandibular Gland
J. Biol. Chem., February 20, 2009; 284(8): 4815 - 4822.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
Y. Fujiwara, B. Keceli, K. Nakajo, and Y. Kubo
Voltage- and [ATP]-dependent Gating of the P2X2 ATP Receptor Channel
J. Gen. Physiol., January 1, 2009; 133(1): 93 - 109.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L.-P. Bernier, A. R. Ase, S. Chevallier, D. Blais, Q. Zhao, E. Boue-Grabot, D. Logothetis, and P. Seguela
Phosphoinositides Regulate P2X4 ATP-Gated Channels through Direct Interactions
J. Neurosci., November 26, 2008; 28(48): 12938 - 12945.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Donnelly-Roberts, S. McGaraughty, C.-C. Shieh, P. Honore, and M. F. Jarvis
Painful Purinergic Receptors
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. R. Dubyak
Go It Alone No More P2X7 Joins the Society of Heteromeric ATP-Gated Receptor Channels
Mol. Pharmacol., December 1, 2007; 72(6): 1402 - 1405.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics